celecoxib has been researched along with hesperetin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Guo, YH; Huang, C; Ji, YR; Li, J; Li, Z; Shi, W; Sun, GP; Zhang, YL; Zheng, Y | 1 |
Guo, Y; Huang, C; Li, J; Li, Z; Shi, W; Xu, T; Zhang, Y; Zheng, Y | 1 |
2 other study(ies) available for celecoxib and hesperetin
Article | Year |
---|---|
Design and synthesis of 7-O-1,2,3-triazole hesperetin derivatives to relieve inflammation of acute liver injury in mice.
Topics: Animals; Carbon Tetrachloride; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Design; Hesperidin; Inflammation; Liver; Mice; Mice, Inbred C57BL; Molecular Structure; Nitric Oxide; RAW 264.7 Cells; Reactive Oxygen Species; Structure-Activity Relationship; Triazoles | 2021 |
Design, Synthesis and Investigation of the Potential Anti-Inflammatory Activity of 7-
Topics: Animals; Celecoxib; Cyclooxygenase 2; Gene Expression Regulation; Hesperidin; Humans; Hydrophobic and Hydrophilic Interactions; Indomethacin; Inflammation; Interleukin-1beta; Interleukin-6; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Signal Transduction; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2019 |